Rituximab BS IV infusion 100mg “KHK”, manufactured by Sand, contains Rituximab (genetical recombination) [Rituximab follow-on 1], a monoclonal antibody that targets the CD20 protein on B cells. Rituximab biosimilars are used to treat various CD20-positive Non-Hodgkin’s lymphomas, chronic lymphocytic leukemia, and autoimmune conditions. This 100mg 10mL 1 bottle has a YJ code of 4291439A1027.
Rituximab BS IV infusion 100mg “KHK”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →